Bluejay Diagnostics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Bluejay Diagnostics, Inc. (BJDX) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $1.56 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-12
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.56K.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2.97K.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $4.79K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $7.01K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount as first filed |
|---|---|---|
| 2026-06-30 | $1.56K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $2.97K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $4.79K 10-K · filed 2026-03-06 | |
| 2025-09-30 | $7.01K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $9.62K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $12.63K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $16.01K 10-K · filed 2025-03-31 | |
| 2024-09-30 | $19.80K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $24.22K 10-Q · filed 2024-08-14 | |
| 2023-12-31 | $29.30K 10-Q · filed 2024-05-15 | $35.01K 10-K · filed 2024-03-28 |
| 2023-09-30 | $2.80K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $48.33K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $55.90K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $64.08K 10-K · filed 2023-03-20 | |
| 2022-09-30 | $72.52K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $42.17K 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $26.43K 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |